No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SKYE240621P10000
- 1.03
- +0.28+37.33%
15min DelayClose Jun 18 16:00 ET
1.03High1.03Low
1.03Open0.75Pre Close2 Volume2 Open Interest10.00Strike Price206.00Turnover834.35%IV5.68%PremiumJun 21, 2024Expiry Date0.49Intrinsic Value100Multiplier1DDays to Expiry0.54Extrinsic Value100Contract SizeAmericanOptions Type-0.4143Delta0.0684Gamma3.73Leverage Ratio-0.7065Theta-0.0003Rho-1.55Eff Leverage0.0027Vega
Intraday
- 5D
- Daily
News
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.Quantum
Cantor Fitzgerald Reiterates Overweight on Skye Bioscience, Maintains $14 Price Target
Cantor Fitzgerald analyst Kristen Kluska reiterates Skye Bioscience (NASDAQ:SKYE) with a Overweight and maintains $14 price target.
Skye Bioscience Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/17/2024 33.59% Cantor Fitzgerald $14 → $14 Reiterates Overweight → Overweight 05/23/2024 100.38% Cantor
Express News | Skye Bioscience Inc : Oppenheimer Cuts Target Price to $21 From $25
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and
Skye Bioscience Pulls Plug on Glaucoma Drug, Stock Tumbles 15%
Comments
$Scorpius Holdings(SCPX.US$ Look at their peers. This is really undervalued. Once in a lifetime opporturnity.
$SKYE BIOSCIENCE INC(SKYE.US$ $Boundless Bio(BOLD.US$
$SKYE BIOSCIENCE INC(SKYE.US$ $Boundless Bio(BOLD.US$
1
$SKYE BIOSCIENCE INC(SKYE.US$
![]()
this just shows it pays to follow up on things..
I had been eyeing this off for a while. Tried to buy in Jan at 0.019-0.020 but then left it alone as for whatever reason I wasn't able to buy.
Now I see it's gone from 0.02000 to a whopping 3.15.
Damn you Mr Market, that's ice cold!
I had been eyeing this off for a while. Tried to buy in Jan at 0.019-0.020 but then left it alone as for whatever reason I wasn't able to buy.
Now I see it's gone from 0.02000 to a whopping 3.15.
Damn you Mr Market, that's ice cold!
3
cannot believe I tried to buy this at 0.020 a few months ago but said 'stock not supported' .... makes me happy to have been right and furious to not have the cold hard cash on it now $SKYE BIOSCIENCE INC(SKYE.US$
5
could someone help me please, I don't understand why Skye is not supported? Read more
Skinny bulldogOP : Look at the other company in the same industry you will know. The problem is, how high it can go.